STOCK TITAN

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Embecta Corp. (EMBC) to Present at J.P. Morgan Healthcare Conference on January 10, 2024
Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 2:15 p.m. PT / 5:15 p.m. ET.

Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

About embecta 
embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.

Contacts:

MediaInvestors
Christian GlazarPravesh Khandelwal
Sr. Director, Corporate CommunicationsVP, Head of Investor Relations
908-821-6922551-264-6547
Contact Media Relations Contact IR

Embecta Corp. will present at 2:15 p.m. PT / 5:15 p.m. ET.

The audio webcasts will be accessible under the 'News & Events' section of the Company's investor relations website at investors.embecta.com.
Embecta Corp

NASDAQ:EMBC

EMBC Rankings

EMBC Latest News

EMBC Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing